Haoyuan Pharmaceutical (688131.SH) has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds.

Hao Yuan Pharmaceuticals (688131.SH) announced that on September 21, 2024, the company received the notice issued by the China Securities Regulatory Commission...

Zhitong FinanceSep 23 04:56 ET

Earnings Tell The Story For Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) As Its Stock Soars 27%

Simply Wall StSep 22 20:40 ET

There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings

Simply Wall StSep 4 18:32 ET

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥855m Last Week

Simply Wall StAug 30 20:27 ET

Shanghai Haoyuan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

SZSIAug 28 12:00 ET · Announcements

Summary of the 2024 semi-annual report of Shanghai Haoyuan Pharmaceutical Co., Ltd.

SZSIAug 28 12:00 ET · Announcements